Back to videosOrthopedic M&A activity is on track for a historically low year. ORTHOWORLD’s Carolyn LaWell and Mike Evers discuss the reasons behind the slowdown, analyze the key companies making moves in this challenging environment and provide an outlook for the remainder of the year.
Key highlights include:
- Only 3 deals closed in 2024
- M&A volume down 40% since 2021
- Companies to watch: Stryker, Enovis, Smith+Nephew
Seek deeper analysis? Our downloadable M&A Tracker contains data back to 1993.
